Cost-Effectiveness Analysis of Treatments for Myocardial Infarction
Author Information
Author(s): Liu Yanmei, Koustuv Dalal
Primary Institution: Karolinska Institutet, Sweden; Linkoping University, Sweden
Hypothesis
What is the cost-effectiveness of various medications used to treat myocardial infarction?
Conclusion
Thrombolytic agents and other medications are generally cost-effective for treating myocardial infarction across various countries.
Supporting Evidence
- Five out of eight studies focused on thrombolytic therapies.
- Thrombolytic agents have been shown to be cost-effective in many studies since the 1980s.
- Various medications including thrombolytic agents, ACEI, and heparin are cost-effective for MI treatment.
Takeaway
This study looks at how much different medicines for heart attacks cost and how well they work, finding that some treatments are really good deals for the money.
Methodology
The study reviewed eight articles on cost-effectiveness analysis of medications for myocardial infarction, focusing on thrombolytic agents and other treatments.
Limitations
The review is limited to articles published in English and may not cover all relevant studies.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI:0.10-0.23
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website